login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Aequus Pharmaceuticals Inc (AQS.CA) Stock News
TSX-V:AQS - TSX Venture Exchange -
CA0076361033
-
Common Stock
- Currency: CAD
0.005
0 (0%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AQS.CA Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Aequus Pharmaceuticals
Aequus Reports Second Quarter 2023 Financial Highlights and General Update
2 years ago - By: Aequus Pharmaceuticals
Aequus Announces Zimed PF Now Available in Canada
2 years ago - By: Aequus Pharmaceuticals
Aequus Announces Zimed PF Website Launch
2 years ago - By: Aequus Pharmaceuticals
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada
2 years ago - By: Aequus Pharmaceuticals
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)
2 years ago - By: Aequus Pharmaceuticals
Aequus Provides General Update and First Quarter 2023 Financial Highlights
2 years ago - By: Aequus Pharmaceuticals
Aequus Grants Stock Options
2 years ago - By: Aequus Pharmaceuticals
Aequus Provides General Update and Fiscal 2022 Financial Results
2 years ago - By: Aequus Pharmaceuticals
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update
3 years ago - By: Aequus Pharmaceuticals
Aequus Announces Health Canada Notice of Compliance (NOC) for ZimedĀ® Preservative Free (Bimatoprost 0.03%)
3 years ago - By: Aequus Pharmaceuticals
Aequus Reports Third Quarter 2022 Financial Highlights
3 years ago - By: Aequus Pharmaceuticals
Aequus Reports Second Quarter 2022 Financial Highlights and General Update
3 years ago - By: Aequus Pharmaceuticals
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.
3 years ago - By: Aequus Pharmaceuticals
Aequus Resumes Trading on TSX Venture Exchange
3 years ago - By: Aequus Pharmaceuticals
Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products
3 years ago - By: Aequus Pharmaceuticals
Aequus Provides General Update and Reports Record 2021 Financial Results
3 years ago - By: Aequus Pharmaceuticals
Aequus Provides Update on Delay in Filing Annual Financial Statements
3 years ago - By: Aequus Pharmaceuticals
Aequus Provides Update on Delay in Filing Annual Financial Statements
3 years ago - By: Aequus Pharmaceuticals
Aequus Provides Update on Delay in Filing Annual Financial Statements
3 years ago - By: Aequus Pharmaceuticals
Aequus Announces Delay in Filing Annual Financial Statements
3 years ago - By: Aequus Pharmaceuticals
Aequus Announces Short Term Loan
3 years ago - By: Aequus Pharmaceuticals
Aequus Announces Director Resignation
4 years ago - By: Aequus Pharmaceuticals
Aequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma Medication
4 years ago - By: Stock News Now
- Mentions:
AKR.CA
ADCO.CA
ACOG.CA
ALY.CA
...
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
4 years ago - By: Aequus Pharmaceuticals
Aequus Reports Third Quarter 2021 Financial Highlights
Please enable JavaScript to continue using this application.